Biotech is beauty’s new frontier, delivering an unbeatable advantage in the market: heightened performance, true product innovation and unrivalled sustainability.
While sustainability is integral to biotech’s processes, biotech’s key selling point is superior performance. Just as biotech has unlocked growth in pharma driven by potency, purity, performance and safety, so too it is driving growth in beauty, albeit at an accelerated pace due to an easier regulatory environment.
Debut, the biotech beauty leader, is driving the charge. With BiotechXBeautyLabs™, the company’s biotech custom formulation and contract manufacturing division, we make it possible for all beauty brands globally to develop novel, science-backed, peak-performing and 95% bio-based formulations – minus the heavy investment associated with biotech R&D.
Join Joshua Britton, Founder & CEO of Debut, and Taylor Oswald, Director of Ingredient and Product Innovation, to discover how biotech is pushing the boundaries of what’s next in beauty. They presented the newly launched DermCeuticalPRO™ collection that delivers best-in-class performance and claims, including for epidermal barrier repair, inflammaging and longevity, significantly surpassing leading benchmarks.
Topics covered included:
Terms & Conditions | Privacy Policy | Contact us at info@hpcimedia.com
© HPCi Media Limited | Registered in England No. 6716035 | Studio 227-8, Metal Box Factory, 30 Great Guildford St, London SE1 0HS | VAT GB 939828072